(Q73802736)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320950%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Stature as a prognostic factor in cystic fibrosis survival (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320950%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

Beker LT

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320950%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Russek-Cohen E

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320950%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

Fink RJ

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320950%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 April 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320950%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American Dietetic Association

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320950%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

101

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320950%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320950%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

438-442

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320950%20AND%20SRC:MED&resulttype=core&format=json

The changing epidemiology of cystic fibrosis

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Cystic fibrosis: new perceptions, new strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Cystic fibrosis: molecular biology and therapeutic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Nutritional assessment and management in cystic fibrosis: a consensus report. The Consensus Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Nutritional status of children with cystic fibrosis measured by total body potassium as a marker of body cell mass: Lack of sensitivity of anthropometric measures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

A comparison of survival, growth, and pulmonary function in patients with cystic fibrosis in Boston and Toronto

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Determinants of mortality from cystic fibrosis in Canada, 1970-1989.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Comparison of growth status of patients with cystic fibrosis between the United States and Canada

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Classification and definition of protein-calorie malnutrition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Growth in children with chronic lung disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Nutritional management of cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Nutritional imperatives in cystic fibrosis therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Physical growth: National Center for Health Statistics percentiles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Gender gap in cystic fibrosis mortality

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Nutrition in adults with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Malnutrition in children with cystic fibrosis: the energy-balance equation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Prospective evaluation of resting energy expenditure, nutritional status, pulmonary function, and genotype in children with cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Symposium: Causes and Etiology of Stunting. Introduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Burden of infection on growth failure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Nutrition intervention for weight gain in cystic fibrosis: a meta analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Effectiveness and safety of small vs. large doses of enteric coated pancreatic enzymes in reducing steatorrhea in children with cystic fibrosis: a prospective randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Comparison of weight-based dosages of enteric-coated microtablet enzyme preparations in patients with cystic fibrosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Management of pulmonary disease in patients with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Longitudinal, prospective analysis of dietary intake in children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Enteral nutrition for patients with cystic fibrosis: comparison of a semi-elemental and nonelemental formula

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Behavioral intervention to improve calorie intake of children with cystic fibrosis: treatment versus wait list control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Enhancing nutrition in cystic fibrosis with comprehensive therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Clinical longitudinal standards for height and height velocity for North American children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

Risk of persistent growth impairment after alternate-day prednisone treatment in children with cystic fibrosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8223%2801%2900113-4

10.1016/S0002-8223(01)00113-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11320950%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference